← 返回

高级别浆液性卵巢癌患者总生存期改善与含 NK 细胞、T 细胞和巨噬细胞的 CD16a⁺ 免疫邻域相关

英文原题:Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.

查看英文原题

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.

PubMed 2024/01/22(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

含有 CD16a+细胞的免疫细胞邻域与 HGSC 患者 OS 和 PFS 改善相关。免疫邻域的模式可区分患者结局,并可能为未来更精确的治疗方法提供信息。

研究思路结论见上方概要

对于卵巢高级别浆液性癌(HGSC)患者,过去半个世纪以来生存率一直停滞不前。尽管存在肿瘤突变和免疫细胞浸润,现有免疫疗法对HGSC收效甚微。这些观察结果凸显了人们对免疫系统如何在HGSC肿瘤内发挥功能和相互作用的认知空白。

我们分析了939例HGSC患者的重复核心样本,以了解免疫细胞浸润模式、定位及其与临床特征的关联。我们采用高参数免疫组化/Opal多重染色、数字病理学、计算生物学和多变量分析来识别免疫细胞亚群及其与HGSC肿瘤的关联。

我们通过对细胞亚群进行空间限制的无监督聚类,定义了六种细胞浸润模式。每种模式在大多数患者样本中都有一定程度的体现,但其具体分布各不相同。总生存期(OS)和无进展生存期(PFS)与CD16a+细胞的高浸润及其与巨噬细胞、T细胞、NK细胞在我们通过空间评估定义的六种细胞邻域之一的共定位相对应。

展开英文摘要原文

For patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These observations highlight a gap in the understanding of how the immune system functions and interacts within HGSC tumors.

We analyzed duplicate core samples from 939 patients with HGSC to understand patterns of immune cell infiltration, localization, and associations with clinical features. We used high-parameter immunohistochemical/Opal multiplex, digital pathology, computational biology, and multivariate analysis to identify immune cell subsets and their associations with HGSC tumors.

We defined six patterns of cellular infiltration by spatially restricted unsupervised clustering of cell subsets. Each pattern was represented to some extent in most patient samples, but their specific distributions differed. Overall (OS) and progression-free survival (PFS) corresponded with higher infiltration of CD16a + cells, and their co-localization with macrophages, T cells, NK cells, in one of six cellular neighborhoods that we defined with our spatial assessment.

Immune cell neighborhoods containing CD16a+ cells are associated with improved OS and PFS for patients with HGSC. Patterns of immunologic neighborhoods differentiate patient outcomes, and could inform future, more precise approaches to treatment.

论文信息

作者
Nersesian S、Arseneau RJ、Mejia JP、Lee SN、Westhaver LP、Griffiths NW、Grantham SR、Meunier L
单位
Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.Canada
文献类型
非美国政府资助研究
期刊
Frontiers in immunology2023
原文标识
PubMed 38318505 · DOI 10.3389/fimmu.2023.1307873